{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:17Z","timestamp":1707525137494},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,12]]},"DOI":"10.7759\/cureus.38945","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T19:59:01Z","timestamp":1683921541000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuromyelitis Optica: A Case Report From a Radiological Perspective"],"prefix":"10.7759","author":[{"given":"Zubir S","family":"Rentiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogbonnaya","family":"Akuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinwe C","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr. Aadil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117225","article-title":"Neuromyelitis optica spectrum disorders","volume":"420","author":"Paul S","year":"2021","unstructured":"Paul S, Mondal GP, Bhattacharyya R, Ghosh KC, Bhat IA. Neuromyelitis optica spectrum disorders. J Neurol Sci. 2021, 420:117225. 10.1016\/j.jns.2020.117225","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016, 13:280. 10.1186\/s12974-016-0718-0","journal-title":"J Neuroinflammation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda S","year":"2019","unstructured":"Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Neuromyelitis optica spectrum disorders. Clin Med (Lond). 2019, 19:169-76. 10.7861\/clinmedicine.19-2-169","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon VA","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, et al.. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364:2106-12. 10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi S","year":"2019","unstructured":"Shahmohammadi S, Doosti R, Shahmohammadi A, et al.. Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord. 2019, 27:350-63. 10.1016\/j.msard.2018.11.008","journal-title":"Mult Scler Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102921","article-title":"Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges","volume":"21","author":"Liu C","year":"2022","unstructured":"Liu C, Shi M, Zhu M, Chu F, Jin T, Zhu J. Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges. Autoimmun Rev. 2022, 21:102921. 10.1016\/j.autrev.2021.102921","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama S","year":"2018","unstructured":"Salama S, Marouf H, Ihab Reda M, Mansour AR, ELholy O, Levy M. Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta. J Neuroimmunol. 2018, 324:22-5. 10.1016\/j.jneuroim.2018.08.014","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.09.008","article-title":"Transverse myelitis","volume":"31","author":"Beh SC","year":"2013","unstructured":"Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin. 2013, 31:79-138. 10.1016\/j.ncl.2012.09.008","journal-title":"Neurol Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170690","article-title":"Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review","volume":"91","author":"Wang KY","year":"2018","unstructured":"Wang KY, Chetta J, Bains P, Balzer A, Lincoln J, Uribe T, Lincoln CM. Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review. Br J Radiol. 2018, 91:20170690. 10.1259\/bjr.20170690","journal-title":"Br J Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos MC","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol. 2014, 10:493-506. 10.1038\/nrneurol.2014.141","journal-title":"Nat Rev Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-021-00667-3","article-title":"New therapeutic landscape in neuromyelitis optica","volume":"23","author":"Tugizova M","year":"2021","unstructured":"Tugizova M, Vlahovic L, Tomczak A, Wetzel NS, Han MH. New therapeutic landscape in neuromyelitis optica. Curr Treat Options Neurol. 2021, 23:13. 10.1007\/s11940-021-00667-3","journal-title":"Curr Treat Options Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152112-neuromyelitis-optica-a-case-report-from-a-radiological-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:29Z","timestamp":1707508829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152112-neuromyelitis-optica-a-case-report-from-a-radiological-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.38945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}